Polzastobart Biosimilar - Research Grade

Human

LILRB2

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2952

Q8N423

Blue ice

LILRB2 is an inhibitory leukocyte immunoglobulin-like receptor that modulates myeloid cell activity and is increasingly studied as a target for reprogramming the tumour microenvironment. This anti-human LILRB2 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of polzastobart, made strictly for research use only. Produced to demanding in vivo standards and purified to a low-endotoxin grade, it is available in scalable milligram (mg) to gram (g) quantities to support bulk and high-throughput laboratories. It serves as a reliable reagent in myeloid checkpoint studies, in vitro screening, functional assays, and in vivo immuno-oncology models.

Detects human LILRB2

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks